This page lists insider trading activity reported for Pfizer (PFE). InsiderCompass processes every SEC Form 4 filing by Pfizer executives, directors, and 10% beneficial owners to list discretionary open-market purchases (transaction code P).
Healthcare insider trading encompasses a wide range of subsectors including pharmaceuticals, medical devices, diagnostics, and healthcare services. InsiderCompass processes all SEC Form 4 filings from healthcare companies to identify discretionary purchases by executives and directors.
InsiderCompass reports discretionary purchases by healthcare insiders and groups multi-insider purchases under published criteria.
InsiderCompass processes SEC Form 4 filings daily to track insider trading activity. Each transaction is classified as discretionary or non-discretionary based on transaction codes, footnote analysis, and 10b5-1 plan indicators. Transaction code P marks a purchase; a purchase the filing reports as made under a 10b5-1 plan is classified as non-discretionary.
InsiderCompass groups purchases by two or more insiders at the same company within a seven-day sliding window, with a combined value of at least $50,000, as a multi-insider purchase.
View the latest insider buying activity for Pfizer (PFE) including Form 4 filings, purchase amounts, and insider names on InsiderCompass.
InsiderCompass tracks all Form 4 insider transactions for Pfizer including open-market purchases, sales, option exercises, and multi-insider purchases.
PFE Form 4 filings show insider purchases and sales by executives, directors, and 10% owners. InsiderCompass reports these filings and the resulting change in each insider’s holdings.
Loading insider trading data...